Literature DB >> 12876147

Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases.

Matthew A Lambon Ralph1, Karalyn Patterson, Naida Graham, Kate Dawson, John R Hodges.   

Abstract

This study investigated cross-sectional and longitudinal neuropsychological data from 55 patients: 38 with Alzheimer's disease and 18 with mild cognitive impairment (MCI). The analyses were designed to investigate two issues: the relationship of MCI to Alzheimer's disease, and that of atypical to typical Alzheimer's disease. When longitudinal data were averaged across individual patients, a consistent staging of neuropsychological deficits emerged: the selective amnesia characteristic of the MCI phase was joined next by semantic and other linguistic impairments plus emerging difficulties with demanding visuospatial tasks. A two-stage statistical procedure was used to extract underlying factors that corresponded to the severity-governed decline in neuropsychological test scores and then to the consistent deviations away from this typical longitudinal profile; i.e. identifying patterns of atypical Alzheimer's disease. The severity-based factor accounted for nearly 60% of the variance in this MCI-Alzheimer's disease longitudinal and cross-sectional database. This suggests that there is a fairly high degree of homogeneity within this group of patients, and that most of their longitudinal progression can be predicted by dementia severity alone. There were also two main patterns of atypical variation corresponding to patients with exaggerated semantic or visuospatial deficits. Although such cases may mimic more focal lobar degenerative conditions, patients with atypical Alzheimer's disease have pronounced episodic memory impairments, suggesting amnesia as a critical diagnostic feature.

Entities:  

Mesh:

Year:  2003        PMID: 12876147     DOI: 10.1093/brain/awg236

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  43 in total

1.  [New possibilities for automated diagnosis of dementia].

Authors:  S Klöppel
Journal:  Nervenarzt       Date:  2010-12       Impact factor: 1.214

2.  Altered Gray Matter Structural Covariance Networks in Early Stages of Alzheimer's Disease.

Authors:  Maxime Montembeault; Isabelle Rouleau; Jean-Sébastien Provost; Simona Maria Brambati
Journal:  Cereb Cortex       Date:  2015-05-20       Impact factor: 5.357

3.  Anomia as a marker of distinct semantic memory impairments in Alzheimer's disease and semantic dementia.

Authors:  Jamie Reilly; Jonathan E Peelle; Sharon M Antonucci; Murray Grossman
Journal:  Neuropsychology       Date:  2011-07       Impact factor: 3.295

Review 4.  The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.

Authors:  Abdelmagid M Elmatboly; Ahmed M Sherif; Dalia A Deeb; Amira Benmelouka; May N Bin-Jumah; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2020-02-19       Impact factor: 4.223

5.  Delay and probability discounting as candidate markers for dementia: an initial investigation.

Authors:  Cutter A Lindbergh; Antonio N Puente; Joshua C Gray; James Mackillop; L Stephen Miller
Journal:  Arch Clin Neuropsychol       Date:  2014-09-18       Impact factor: 2.813

6.  Verbal fluency predicts mortality in Alzheimer disease.

Authors:  Stephanie Cosentino; Nikolaos Scarmeas; Steven M Albert; Yaakov Stern
Journal:  Cogn Behav Neurol       Date:  2006-09       Impact factor: 1.600

7.  Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.

Authors:  Antonella Caccamo; Ramona Belfiore; Salvatore Oddo
Journal:  Neurobiol Aging       Date:  2018-04-05       Impact factor: 4.673

8.  Neuropsychological characteristics of mild cognitive impairment subgroups.

Authors:  O L Lopez; J T Becker; W J Jagust; A Fitzpatrick; M C Carlson; S T DeKosky; J Breitner; C G Lyketsos; B Jones; C Kawas; L H Kuller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

Review 9.  Diagnosis and treatment of dementia: 2. Diagnosis.

Authors:  Howard H Feldman; Claudia Jacova; Alain Robillard; Angeles Garcia; Tiffany Chow; Michael Borrie; Hyman M Schipper; Mervin Blair; Andrew Kertesz; Howard Chertkow
Journal:  CMAJ       Date:  2008-03-25       Impact factor: 8.262

10.  Objective metamemory testing captures awareness of deficit in Alzheimer's disease.

Authors:  Stephanie Cosentino; Janet Metcalfe; Brady Butterfield; Yaakov Stern
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.